影响失眠障碍睡眠-清醒不一致性的神经生理学参数:在睡眠开始期间对阿尔法节律的初步分析
Francesca Berra1,2, Elisabetta Fasiello1,2, Marco Zucconi2
1Department of Psychology, "Vita-Salute" San Raffaele University, 20132 Milan, Italy.
Brain sciences
|January 26, 2024
概括
在失眠障碍中,睡眠状态的误解与大脑过度兴奋有关. 睡眠延迟期间阿尔法大脑活动增加和REM兴奋密度预测睡眠时间的误解.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 精神病学是一个精神病学.
背景情况:
- 睡眠状态误解 (SSM) 是失眠障碍 (ID) 中普遍存在的问题,其特点是睡眠/清醒估计的差异,导致白天障碍.
- 过度兴奋理论认为,持续的中枢神经系统激活是ID中SSM的基础.
研究的目的:
- 调查在失眠障碍患者的睡眠延迟 (SL) 和总睡眠时间 (TST) 期间影响睡眠状态误解的因素.
- 探索客观的多睡眠测量和主观的睡眠感知之间的关系.
主要方法:
- 从16名ID患者的睡眠日记中分析了客观的多睡眠数据 (α密度指数,睡眠阶段延迟,REM唤醒密度) 和主观的睡眠指数.
- 使用相关性和回归分析来确定SSM的预测因素.
主要成果:
- 在睡眠延迟误解 (SLm) 和在客观SL时存在的α节律之间发现了积极的关联.
- 快觉醒密度和α密度指数显著预测了总睡眠时间误解 (TSTm).
- 增加的SLm与从第1阶段NREM睡眠过渡到清醒的可能性更高相关.
结论:
- 研究结果支持过度兴奋理论在失眠障碍中对睡眠状态的误解中的作用.
- 阿尔法活性和REM兴奋密度是了解SSM多种机制的关键因素.
相关概念视频
Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
Management of Insomnia
250
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
250
Insomnia
86
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
86
Insufficient Sleep and Sleep Deprivation
144
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
144
Narcolepsy
103
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
103
Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176


